ResMed Inc. Peer Comparison
Metric | Value | Ranking | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $36.9 Billion | 2/11 | BDX $50.3B |
RMD $36.9B |
COO $16.6B |
BAX $16.2B |
WST $15.6B |
HOLX $12.7B |
MMSI $5.8B |
TFX $5.7B |
ICUI $3.5B |
STAA $951.9M |
EMBC $702.5M |
Gross Margin | 59% | 4/11 | COO 68% |
STAA 65% |
EMBC 60% |
RMD 59% |
HOLX 57% |
TFX 55% |
MMSI 49% |
BDX 43% |
WST 37% |
ICUI 36% |
BAX 35% |
Profit Margin | 27% | 1/11 | RMD 27% |
HOLX 20% |
WST 17% |
COO 11% |
MMSI 8% |
BDX 6% |
EMBC 0% |
ICUI -4% |
TFX -17% |
BAX -19% |
STAA -70% |
EBITDA margin | 28% | 2/11 | HOLX 34% |
RMD 28% |
WST 27% |
COO 19% |
EMBC 15% |
ICUI 14% |
MMSI 10% |
BDX 9% |
TFX -5% |
BAX -6% |
STAA -82% |
Quarterly Revenue | $1.3 Billion | 3/11 | BDX $5.2B |
BAX $2.8B |
RMD $1.3B |
HOLX $1.0B |
COO $964.7M |
TFX $795.4M |
WST $748.8M |
ICUI $629.8M |
MMSI $355.2M |
EMBC $261.9M |
STAA $48,950 |
Quarterly Earnings | $344.6 Million | 1/11 | RMD $344.6M |
BDX $303.0M |
HOLX $201.0M |
WST $130.1M |
COO $104.3M |
MMSI $27.9M |
STAA -$34,228 |
EMBC -$700,000 |
ICUI -$23.8M |
TFX -$136.7M |
BAX -$512.0M |
Quarterly Free Cash Flow | $289.7 Million | 3/11 | BDX $588.0M |
BAX $351.0M |
RMD $289.7M |
HOLX $172.5M |
TFX $170.4M |
COO $101.2M |
WST $85.2M |
ICUI $13.6M |
EMBC -$6.8M |
MMSI -$0 |
STAA -$0 |
Trailing 4 Quarters Revenue | $4.9 Billion | 3/11 | BDX $20.6B |
BAX $12.9B |
RMD $4.9B |
HOLX $4.0B |
COO $3.9B |
TFX $3.0B |
WST $2.9B |
ICUI $2.4B |
MMSI $1.4B |
EMBC $1.1B |
STAA $265.0M |
Trailing 4 Quarters Earnings | $1.2 Billion | 2/11 | BDX $5.2B |
BAX $2.8B |
RMD $1.3B |
HOLX $1.0B |
COO $964.7M |
TFX $795.4M |
WST $748.8M |
ICUI $629.8M |
MMSI $355.2M |
EMBC $261.9M |
STAA $48,950 |
Quarterly Earnings Growth | 65% | 1/11 | RMD 65% |
COO 28% |
BDX 8% |
MMSI 1% |
WST -5% |
HOLX -18% |
ICUI -39% |
STAA -100% |
EMBC -103% |
BAX -309% |
TFX -539% |
Annual Earnings Growth | 44% | 4/11 | BDX 135% |
STAA 80% |
EMBC 51% |
RMD 44% |
HOLX 44% |
COO 24% |
MMSI 14% |
WST -21% |
TFX -84% |
BAX -108% |
ICUI -2677% |
Quarterly Revenue Growth | 10% | 2/11 | HOLX 268% |
RMD 10% |
BDX 10% |
MMSI 9% |
ICUI 7% |
TFX 3% |
WST 2% |
COO 0% |
EMBC -6% |
BAX -29% |
STAA -100% |
Annual Revenue Growth | 22% | 4/11 | STAA 246% |
COO 41% |
HOLX 30% |
RMD 22% |
MMSI 7% |
ICUI 6% |
BDX 3% |
TFX 1% |
EMBC -1% |
WST -3% |
BAX -14% |
Cash On Hand | $521.9 Million | 4/11 | HOLX $1.8B |
BAX $1.8B |
BDX $711.0M |
RMD $521.9M |
WST $484.6M |
MMSI $376.7M |
ICUI $308.6M |
TFX $290.2M |
EMBC $210.0M |
COO $100.9M |
STAA $144,159 |
Short Term Debt | $37.7 Million | 7/11 | BAX $2.8B |
BDX $1.3B |
TFX $100.0M |
HOLX $53.4M |
ICUI $51.0M |
COO $49.7M |
RMD $37.7M |
WST $17.9M |
EMBC $12.9M |
MMSI $10.3M |
STAA $3,936 |
Long Term Debt | $802.0 Million | 7/11 | BDX $17.4B |
BAX $10.6B |
COO $2.5B |
TFX $1.7B |
EMBC $1.6B |
ICUI $1.5B |
RMD $802.0M |
MMSI $799.8M |
WST $284.4M |
HOLX $22.2M |
STAA $34,807 |
PE | 29.55 | 6/11 | TFX 82.00 |
STAA 68.06 |
MMSI 48.53 |
COO 39.92 |
WST 31.59 |
RMD 29.55 |
BDX 28.76 |
HOLX 17.01 |
EMBC 12.22 |
BAX -1.00 |
ICUI -1.00 |
PS | 7.49 | 1/11 | RMD 7.49 |
WST 5.38 |
MMSI 4.31 |
COO 4.22 |
STAA 3.59 |
HOLX 3.13 |
BDX 2.44 |
TFX 1.87 |
ICUI 1.46 |
BAX 1.26 |
EMBC 0.63 |
PB | 7.03 | 2/11 | STAA 2395.69 |
RMD 7.03 |
WST 5.80 |
MMSI 4.23 |
HOLX 2.65 |
BAX 2.31 |
COO 2.04 |
BDX 1.99 |
ICUI 1.77 |
TFX 1.34 |
EMBC 0.00 |
PC | 70.71 | 3/11 | STAA 6603.07 |
COO 164.35 |
RMD 70.71 |
BDX 70.71 |
WST 32.12 |
TFX 19.69 |
MMSI 15.50 |
ICUI 11.28 |
BAX 9.21 |
HOLX 7.10 |
EMBC 3.35 |
Liabilities to Equity | 0.36 | 8/11 | BAX 2.69 |
BDX 1.17 |
ICUI 1.14 |
HOLX 0.83 |
MMSI 0.75 |
TFX 0.66 |
COO 0.50 |
RMD 0.36 |
WST 0.36 |
STAA 0.28 |
EMBC 0.00 |
ROA | 0.17 | 2/11 | STAA 2745% | RMD 17% | WST 14% | HOLX 9% | MMSI 5% | EMBC 5% | BDX 3% | COO 3% | TFX 1% | BAX -3% | ICUI -3% |
ROE | 0.24 | 2/11 | STAA 3520% |
RMD 24% |
WST 18% |
HOLX 16% |
MMSI 9% |
BDX 7% |
COO 5% |
TFX 2% |
ICUI -6% |
EMBC -7% |
BAX -9% |
Current Ratio | 3.78 | 3/11 | STAA 4.54 |
WST 3.79 |
RMD 3.78 |
COO 2.98 |
TFX 2.52 |
MMSI 2.33 |
HOLX 2.21 |
ICUI 1.88 |
BDX 1.86 |
BAX 1.37 |
EMBC 0.60 |
Quick Ratio | 0.28 | 5/11 | TFX 82.00 |
STAA 68.06 |
MMSI 48.53 |
COO 39.92 |
WST 31.59 |
RMD 29.55 |
BDX 28.76 |
HOLX 17.01 |
EMBC 12.22 |
BAX -1.00 |
ICUI -1.00 |
Long Term Debt to Equity | 0.15 | 7/11 | BAX} 1.52 |
ICUI} 0.78 |
BDX} 0.69 |
MMSI} 0.58 |
TFX} 0.39 |
COO} 0.31 |
RMD} 0.15 |
WST} 0.11 |
STAA} 0.09 |
HOLX} 0.00 |
EMBC} -2.03 |
Debt to Equity | 0.16 | 7/11 | BAX 1.93 |
ICUI 0.81 |
BDX 0.74 |
MMSI 0.59 |
TFX 0.41 |
COO 0.31 |
RMD 0.16 |
WST 0.11 |
STAA 0.10 |
HOLX 0.01 |
EMBC -2.05 |
Burn Rate | -1.72 | 9/11 | MMSI 56.84 |
COO 12.98 |
STAA 3.94 |
EMBC 3.16 |
ICUI 3.15 |
TFX 1.27 |
BAX 1.07 |
BDX 0.98 |
RMD -1.72 |
WST -4.24 |
HOLX -9.54 |
Cash to Cap | 0.01 | 8/11 | EMBC 0.30 |
HOLX 0.14 |
BAX 0.11 |
ICUI 0.09 |
MMSI 0.06 |
TFX 0.05 |
WST 0.03 |
RMD 0.01 |
BDX 0.01 |
COO 0.01 |
STAA 0.00 |
CCR | 0.84 | 5/11 | EMBC 9.71 |
BDX 1.94 |
COO 0.97 |
HOLX 0.86 |
RMD 0.84 |
WST 0.65 |
ICUI -0.57 |
BAX -0.69 |
TFX -1.25 |
MMSI |
STAA |
EV to EBITDA | 102.77 | 4/11 | MMSI} 171.60 |
BDX} 150.82 |
COO} 104.51 |
RMD} 102.77 |
WST} 75.11 |
ICUI} 54.38 |
EMBC} 52.94 |
HOLX} 31.02 |
BAX} -158.71 |
TFX} -197.56 |
STAA} -23823.24 |
EV to Revenue | 7.56 | 1/11 | RMD 7.56 |
WST 5.32 |
COO 4.84 |
MMSI 4.63 |
STAA 3.59 |
BDX 3.31 |
HOLX 2.70 |
TFX 2.36 |
BAX 2.17 |
ICUI 2.00 |
EMBC 1.87 |